Neeraj Agarwal: Congrats Shilpa Gupta for oral ASCO 2025 Abstract on mUC Bladder Cancer

Neeraj Agarwal: Congrats Shilpa Gupta for oral ASCO 2025 Abstract on mUC Bladder Cancer

Neeraj Agarwal, Professor of Medicine and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), shared a post on X:

“Congrats Shilpa Gupta for oral abstract #4502 ASCO25
In the Ph3 EV-302 trial in mUC bladder cancer, patients achieving a CR had higher PFS and OS with EV+P vs. chemo (exploratory analysis)”

Abstract Title: Exploratory analysis of responders from the phase 3 EV-302 trial of enfortumab vedotin plus pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC).

Authors: Shilpa Gupta, Jens Bedke, Michiel Van Der Heijden, Begoña Valderrama, Eiji Kikuchi, Jeannie Hoffman-Censits, Gopa Iyer, Christof Vulsteke, Steffen Rausch, Se Hoon Park, Alexandra Drakaki, Waddah Arafat, Umang Swami, Ignacio Duran, Jian-Ri Li, Blanca Homet Moreno, Seema Gorla, Xuesong Yu, Yi-Tsung Lu, Thomas Powles

Read Full Abstract on ASCO.

Shilpa Gupta

More posts featuring ASCO 2025.

Alexandra Drakaki Begoña Valderrama Blanca Homet Moreno cancer Christof Vulsteke Eiji Kikuchi Gopa Iyer Ignacio Duran Jeannie Hoffman-Censits Jens Bedke Jian-Ri Li Michiel van der Heijden Neeraj Agarwal OncoDaily Oncology Se Hoon Park Seema Gorla Shilpa Gupta Steffen Rausch Thomas Powles Umang Swami Waddah Arafat Xuesong Yu Yi-Tsung Lu